MDT:NYE-Medtronic PLC (USD)

COMMON STOCK | Medical Devices |

Last Closing

USD 89.45

Change

+0.06 (+0.07)%

Market Cap

USD 115.25B

Volume

6.32M

Analyst Target

USD 115.83
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists; and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat other non-exclusive diseases and conditions; and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems, and InPen, a smart insulin pen system. The company was founded in 1949 and is headquartered in Galway, Ireland.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-26 )

Largest Industry Peers for Medical Devices

Symbol Name Price(Change) Market Cap
ABT Abbott Laboratories

+0.12 (+0.11%)

USD 196.14B
STE STERIS plc

+0.34 (+0.14%)

USD 23.37B
ZBH Zimmer Biomet Holdings Inc

+1.21 (+1.14%)

USD 21.67B
SNN Smith & Nephew SNATS Inc

+0.29 (+0.95%)

USD 13.37B
GMED Globus Medical

+0.17 (+0.24%)

USD 9.42B
BIO Bio-Rad Laboratories Inc

+16.55 (+5.24%)

USD 9.32B
BIO-B Bio-Rad Laboratories Inc

N/A

USD 8.85B
PEN Penumbra Inc

+4.74 (+2.54%)

USD 7.80B
GKOS Glaukos Corp

+1.19 (+0.94%)

USD 7.15B
INSP Inspire Medical Systems Inc

-1.32 (-0.63%)

USD 6.35B

ETFs Containing MDT

CIB0:XETRA VanEck Bionic Engineering.. 11.14 % 0.00 %

+0.02 (+1.60%)

USD 6.28M
CYBG:LSE VanEck Bionic Engineering.. 9.75 % 0.00 %

-0.13 (1.60%)

N/A
UMDV:SW iShares US Medical Device.. 9.28 % 0.00 %

N/A

N/A
FLV American Century ETF Trus.. 5.39 % 0.00 %

+0.16 (+1.60%)

N/A
HHL-U:CA Harvest Healthcare Leader.. 5.10 % 0.00 %

+0.04 (+1.60%)

N/A
HHL-B:CA Harvest Healthcare Leader.. 5.10 % 0.00 %

+0.05 (+1.60%)

N/A
FHI-B:CA CI Health Care Giants Cov.. 5.03 % 0.00 %

N/A

CAD 0.05B
PCIG Litman Gregory Funds Trus.. 4.80 % 0.00 %

+0.16 (+1.60%)

N/A
ABEQ Absolute Core Strategy ET.. 4.57 % 0.00 %

+0.08 (+1.60%)

USD 0.09B
CAMX Cambiar Aggressive Value .. 4.30 % 0.00 %

+0.43 (+1.60%)

USD 0.06B
DIVP The Advisors’ Inner .. 3.96 % 0.00 %

N/A

USD 6.48M
DIVZ Listed Funds Trust - True.. 3.59 % 0.00 %

+0.05 (+1.60%)

USD 0.12B
AIVL WisdomTree Trust - Wisdom.. 3.47 % 0.00 %

+0.91 (+1.60%)

USD 0.40B
DXQ:CA Dynamic Active Enhanced Y.. 2.53 % 0.00 %

+0.03 (+1.60%)

N/A
GDVD 2.46 % 0.00 %

N/A

N/A
DVND Touchstone ETF Trust - To.. 2.15 % 0.00 %

+0.32 (+1.60%)

USD 0.03B
TDOC:CA TD Global Healthcare Lead.. 2.12 % 0.00 %

+0.15 (+1.60%)

CAD 0.09B
QUVU 2.03 % 0.00 %

N/A

N/A
PUD.B:CA 1.85 % 0.66 %

N/A

N/A
CUD:CA iShares US Dividend Growe.. 1.70 % 0.66 %

+0.33 (+1.60%)

CAD 0.35B
SPYD:XETRA SPDR® S&P US Dividend Ar.. 1.69 % 0.00 %

+0.07 (+1.60%)

USD 3.76B
SPPD:XETRA SPDR® S&P US Dividend Ar.. 1.69 % 0.00 %

+0.03 (+1.60%)

USD 0.13B
SPPD:F SSGA SPDR ETFs Europe I p.. 1.69 % 0.00 %

+0.03 (+1.60%)

N/A
USDV:SW SPDR® S&P US Dividend Ar.. 1.69 % 0.00 %

+0.37 (+1.60%)

USD 3.84B
REVS Columbia Research Enhance.. 1.53 % 0.00 %

+0.17 (+1.60%)

USD 0.06B
TWAR 1.11 % 0.00 %

N/A

N/A
BLV Vanguard Long-Term Bond I.. 0.00 % 0.07 %

+0.09 (+1.60%)

N/A
DTN 0.00 % 0.38 %

N/A

N/A
IHI iShares U.S. Medical Devi.. 0.00 % 0.43 %

+0.26 (+1.60%)

N/A
JDIV 0.00 % 0.12 %

N/A

N/A
VSDA VictoryShares Dividend Ac.. 0.00 % 0.35 %

+0.40 (+1.60%)

USD 0.26B
AIIQ 0.00 % 0.79 %

N/A

N/A
FHI:CA CI Health Care Giants Cov.. 0.00 % 0.75 %

-0.01 (1.60%)

CAD 0.07B
UTRN Vesper U.S. Large Cap Sho.. 0.00 % 0.00 %

+0.24 (+1.60%)

USD 0.02B
JIGB 0.00 % 0.14 %

N/A

N/A
GDNA 0.00 % 0.00 %

N/A

N/A
INAU 0.00 % 0.00 %

N/A

N/A
HWF:CA 0.00 % 0.00 %

N/A

N/A
RXD ProShares UltraShort Heal.. 0.00 % 0.77 %

-0.08 (1.60%)

N/A
RXD ProShares UltraShort Heal.. 0.00 % 0.95 %

-0.08 (1.60%)

N/A
SCHZ Schwab U.S. Aggregate Bon.. 0.00 % 0.04 %

-0.02 (1.60%)

USD 8.47B
SICK 0.00 % 0.95 %

N/A

N/A
VCLT Vanguard Long-Term Corpor.. 0.00 % 0.07 %

+0.08 (+1.60%)

USD 13.72B
VCSH Vanguard Short-Term Corpo.. 0.00 % 0.07 %

-0.05 (1.60%)

USD 35.45B
VIDI Vident International Equi.. 0.00 % 0.63 %

+0.66 (+1.60%)

USD 0.35B
YLD Principal Active High Yie.. 0.00 % 0.65 %

+0.05 (+1.60%)

USD 0.23B
UDVD:LSE SPDR® S&P US Dividend Ar.. 0.00 % 0.00 %

+0.19 (+1.60%)

USD 3.76B
USDV:LSE SPDR S&P US Dividend Aris.. 0.00 % 0.00 %

-0.09 (1.60%)

USD 3.78B
XUKS:LSE db x-trackers FTSE 100 Sh.. 0.00 % 0.00 %

-0.78 (1.60%)

USD 7.18M
OUFH:XETRA 0.00 % 0.00 %

N/A

N/A
DIVS SmartETFs Dividend Builde.. 0.00 % 0.00 %

+0.35 (+1.60%)

USD 0.03B

Market Performance

  Market Performance vs. Industry/Classification (Medical Devices) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 8.58% 65% D 50% F
Dividend Return 1.69% 86% B+ 37% F
Total Return 10.27% 65% D 47% F
Trailing 12 Months  
Capital Gain 13.67% 55% F 44% F
Dividend Return 2.64% 86% B+ 40% F
Total Return 16.32% 58% F 42% F
Trailing 5 Years  
Capital Gain -16.65% 42% F 24% F
Dividend Return 11.27% 100% F 42% F
Total Return -5.38% 46% F 21% F
Average Annual (5 Year Horizon)  
Capital Gain -3.86% 34% F 20% F
Dividend Return -1.33% 34% F 18% F
Total Return 2.53% 100% F 54% F
Risk Return Profile  
Volatility (Standard Deviation) 19.05% 94% A 53% F
Risk Adjusted Return -6.99% 34% F 20% F
Market Capitalization 115.25B 96% N/A 98% N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Dividend Growth

This stock has shown top quartile dividend growth in the previous 5 years compared to its sector

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector